Rekha Hemrajani

CIK 1771213 · View on SEC EDGAR ↗

Insider

First SEC filing: Sept. 25, 2024 · Latest: June 12, 2026

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 21 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

21 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
June 25, 2025 MXCT S 10b5-1 10,684 $2.09 $22,330 39,893 Direct -21.12% Disposed -34.0% (price as of 2026-08-21)
Dec. 2, 2024 ALXO P 30,000 $1.55 $46,500 33,000 Direct +1000.00% Acquired 31.0% (price as of 2026-08-21)
July 21, 2020 ALXO P 3,000 $19.00 $57,000 3,000 Direct — Acquired -89.3% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
June 17, 2026 MXCT Stock Option (right to buy) Common Stock (49,579) $1.13 June 16, 2036 49,579 Acquired
June 10, 2026 BIOA Stock Option (Right to Buy) Common Stock (22,000) $15.48 June 9, 2036 22,000 Acquired
Jan. 20, 2026 ALXO Stock option (right to buy) Common Stock (40,400) $1.32 Jan. 19, 2036 40,400 Acquired
June 18, 2025 MXCT Stock Option (right to buy) Common Stock (50,790) $2.11 June 17, 2035 50,790 Acquired
Jan. 21, 2025 ALXO Stock Option (right to buy) Common Stock (40,400) $1.65 Jan. 20, 2035 40,400 Acquired
Sept. 25, 2024 BIOA Stock Option (Right to Buy) Common Stock (15,000) $18.00 Sept. 24, 2034 15,000 Acquired
June 13, 2024 ALXO Stock Option (right to buy) Common Stock (20,200) $8.44 June 12, 2034 20,200 Acquired
June 11, 2024 MXCT Stock Option (right to buy) Common Stock (40,701) $4.68 June 10, 2034 40,701 Acquired
April 17, 2024 BIOA Stock Option (Right to Buy) Common Stock (28,497) $8.39 April 16, 2034 28,497 Acquired
June 22, 2023 MXCT Stock Option (right to buy) Common Stock (50,000) $4.57 June 21, 2033 50,000 Acquired
June 20, 2023 ALXO Stock Option (right to buy) Common Stock (20,200) $8.14 June 19, 2033 20,200 Acquired
March 20, 2023 MXCT Stock Option (right to buy) Common Stock (40,000) $4.19 March 19, 2033 40,000 Acquired
June 29, 2022 MXCT Stock Option (right to buy) Common Stock (26,900) $4.82 June 28, 2032 26,900 Acquired
June 15, 2022 ALXO Stock Option (right to buy) Common Stock (12,004) $6.67 June 14, 2032 12,004 Acquired
Aug. 9, 2021 MXCT Stock Option (right to buy) Common Stock (10,000) $16.63 Aug. 9, 2031 10,000 Acquired
June 11, 2021 ALXO Stock Option (right to buy) Common Stock (12,004) $59.66 June 10, 2031 12,004 Acquired
March 25, 2019 RCUS Stock Option (right to buy) Common Stock (400,000) $11.23 March 24, 2029 400,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 5 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Sept. 25, 2024 BIOA Stock Option (Right to Buy)→ Common Stock (35,172) 35,172 Direct
Sept. 25, 2024 BIOA Stock Option (Right to Buy)→ Common Stock (28,497) 28,497 Direct
July 29, 2021 MXCT Stock Option (right to buy)→ Common Stock (80,700) 80,700 Direct
July 16, 2020 ALXO Stock Option (right to buy)→ Common Stock (87,378) 87,378 Direct
March 25, 2019 RCUS Common Stock 25,252 Indirect

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

RCUS

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2019 $233,818 $200,000 — — — — $142,266 $3,558,524

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.